PRKCQ inhibition enhances chemosensitivity of triple-negative breast cancer by regulating Bim

por Byerly, Jessica H., Port, Elisa R., Irie, Hanna Y.
Publicado 2020

Analysis of ALK gene in 133 patients with breast cancer revealed polysomy of chromosome 2 and no ALK amplification

por Hanna, Matthew G., Najfeld, Vesna, Irie, Hanna Y., Tripodi, Joseph, Nayak, Anupma
Publicado 2015

PRKCQ promotes oncogenic growth and anoikis resistance of a subset of triple-negative breast cancer cells

por Byerly, Jessica, Halstead-Nussloch, Gwyneth, Ito, Koichi, Katsyv, Igor, Irie, Hanna Y.
Publicado 2016

CDK4: a master regulator of the cell cycle and its role in cancer

por Baker, Stacey J., Poulikakos, Poulikos I., Irie, Hanna Y., Parekh, Samir, Reddy, E. Premkumar
Publicado 2022

PTK6 inhibition promotes apoptosis of Lapatinib-resistant Her2(+) breast cancer cells by inducing Bim

por Park, Sun Hee, Ito, Koichi, Olcott, William, Katsyv, Igor, Halstead-Nussloch, Gwyneth, Irie, Hanna Y.
Publicado 2015

PTK6 regulates growth and survival of endocrine therapy-resistant ER+ breast cancer cells

por Ito, Koichi, Park, Sun Hee, Katsyv, Igor, Zhang, Weijia, De Angelis, Carmine, Schiff, Rachel, Irie, Hanna Y.
Publicado 2017

Distinct roles of Akt1 and Akt2 in regulating cell migration and epithelial–mesenchymal transition

por Irie, Hanna Y., Pearline, Rachel V., Grueneberg, Dorre, Hsia, Maximilian, Ravichandran, Preethi, Kothari, Nayantara, Natesan, Sridaran, Brugge, Joan S.
Publicado 2005

EPRS is a critical regulator of cell proliferation and estrogen signaling in ER(+) breast cancer

por Katsyv, Igor, Wang, Minghui, Song, Won Min, Zhou, Xianxiao, Zhao, Yongzhong, Park, Sun, Zhu, Jun, Zhang, Bin, Irie, Hanna Y.
Publicado 2016

Neoadjuvant study of niraparib in patients with HER2-negative, BRCA-mutated, resectable breast cancer

por Spring, Laura M., Han, Hyo, Liu, Minetta C., Hamilton, Erika, Irie, Hanna, Santa-Maria, Cesar A., Reeves, James, Pan, Peng, Shan, Ming, Tang, Yongqiang, Graham, Julie R., Hazard, Sebastien, Ellisen, Leif W., Isakoff, Steven J.
Publicado 2022

Author Correction: Neoadjuvant study of niraparib in patients with HER2-negative, BRCA-mutated, resectable breast cancer

por Spring, Laura M., Han, Hyo, Liu, Minetta C., Hamilton, Erika, Irie, Hanna, Santa-Maria, Cesar A., Reeves, James, Pan, Peng, Shan, Ming, Tang, Yongqiang, Graham, Julie R., Hazard, Sebastien, Ellisen, Leif W., Isakoff, Steven J.
Publicado 2022

PTK6 Regulates IGF-1-Induced Anchorage-Independent Survival

por Irie, Hanna Y., Shrestha, Yashaswi, Selfors, Laura M., Frye, Fabianne, Iida, Naoko, Wang, Zhigang, Zou, Lihua, Yao, Jun, Lu, Yiling, Epstein, Charles B., Natesan, Sridaran, Richardson, Andrea L., Polyak, Kornelia, Mills, Gordon B., Hahn, William C., Brugge, Joan S.
Publicado 2010

Simultaneous CK2/TNIK/DYRK1 inhibition by 108600 suppresses triple negative breast cancer stem cells and chemotherapy-resistant disease

por Sato, Katsutoshi, Padgaonkar, Amol A., Baker, Stacey J., Cosenza, Stephen C., Rechkoblit, Olga, Subbaiah, D. R. C. Venkata, Domingo-Domenech, Josep, Bartkowski, Alison, Port, Elisa R., Aggarwal, Aneel K., Ramana Reddy, M. V., Irie, Hanna Y., Reddy, E. Premkumar
Publicado 2021